Growth Rate Expected To Increase For The Genito-urinary Drugs Market By 2021 AsPosted by sainath on September 27th, 2018 The genitourinary drugs market covers drugs that are used in the treatment of diseases such as urinary tract infections, male reproductive diseases, voiding diseases, female reproductive diseases, glomerular disorders, urinary calculi, cystic kidney disease, Reno vascular diseases, benign prostate diseases, and other related diseases. Read more: https://www.thebusinessresearchcompany.com/report/genito-urinary-drugs-global-market-report-2018 The global genitourinary drugs market has shown moderate growth in the past years with a CAGR of over 4%. The year 2017 recorded highest ever market value in this industry as per TBRC’s inhouse consultants. TBRC’s latest report show the historic and future trends in the market for each year with sourced reasons to support the growth claims. The report also shows the genitourinary drugs market to grow at a higher CAGR by 2021 as compared to 2017, along with geographies best suited for investments with highest return rate. Sample report: https://www.thebusinessresearchcompany.com/sample.aspx?id=274&type=smp The global genito-urinary drugs market is expected to grow at a compound annual growth rate (CAGR) of around 6%. This growth is mainly due to growing genitourinary disorders like chronic kidney disease (CKD). Going forward, the number of pipeline drugs (ABT-614, Abbott Laboratories and EOS789, Chugai Pharmaceutical) are expected to increase with constant improvements in healthcare infrastructure. Novel drugs such as Cialis which are considerably more effective than the drugs used in multiple-drug therapies, and are affordable in cost are expected to fuel the growth of this market. TBRC’s latest report will cover in depth understanding and calculated impacts of each market factor on a global as well as regional level, to analyze the best investment strategy for this market. Companies included in the report are Daiichi Sankyo Company, Limited, Pfizer Inc, Bayer AG and Astellas Pharma Inc. About The Business Research Company. The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally. Contact Information The Business Research Company Europe: +44 207 1930 708 Asia: +91 8897263534 Americas: +1 315 623 0293 Email: info@tbrc.info Like it? Share it! More by this author |